Diseases of the musculoskeletal system caused by pathologies of connective tissue and cartilaginous structures are widespread among both elderly and young patients. The urgency of solving the problem of effective care for patients with this pathology is very high because it often leads to a significant limitation of work capacity, as well as to disability. Cartalax, a cartilage tissue bioregulator, has been developed for the correction and prevention of connective tissue disorders that occur in various diseases.
Cartalax is a peptide complex containing amino acids that help to normalize cartilage and musculoskeletal system.
Cartalax was clinically tested for its effectiveness in the complex prevention and treatment of patients suffering from osteochondrosis of the spine, osteoarthritis, osteoporosis, after injuries and fractures as well as in the prevention of sclerotic and degenerative processes in the spine and joints of elderly and old age.
The drug is combined with any drugs used for the treatment of this group of diseases. Against the background of Cartalax administration patients noted a significant smoothing of pathological symptoms, including pain, usually characterized by significant resistance to conventional therapy.
Cartalax is well tolerated by patients, with no side effects, complications, contraindications and drug dependence have been identified.
Recommended:
arthritis and arthritis,
osteochondrosis,
osteoporosis,
degenerative-dystrophic diseases of the joints, limbs and spine,
rheumatism,
Trauma sequelae of joints and extremities,
arthropathies of various etiologies,
podagra,
systemic prevention of bone-joint injuries in elite sport.
systemic connective tissue diseases,
preoperative and postoperative periods of joint surgery,
conditions after extreme physical activity,
prevention of degenerative processes in the spine and joints in the elderly and the elderly.
Composition:
Peptide complex AC-4-(alanine, glutamic acid, asparagic acid). Excipients: microcrystalline cellulose (E460), beet sugar, lactose, starch, tween-80. As an additional source of peptides.
Method of use:
Adults: 1-2 capsules 1-2 times daily with meals. Duration of use: 10-30 days. It is reasonable to repeat the course in 4-6 months.
Formation: 20 capsules of 0.2 g
.
Weight | 0.035 kg |
---|
Related products
Buy Cartalax N20 – cartilage peptides with delivery to USA, UK, Europe and over 120 other countries.